Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Magarotto V"'
Autor:
Magarotto V, Thevenon J, Morgan K, ten Seldam S, Iraqi W, Guillaume X, Leclerc M, Graziani-Taugeron C, Rault B, Horchi D
Publikováno v:
Patient Preference and Adherence, Vol Volume 18, Pp 1857-1871 (2024)
Valeria Magarotto,1 Julien Thevenon,2 Kate Morgan,3 Silene ten Seldam,3 Wafae Iraqi,4 Xavier Guillaume,5 Marjorie Leclerc,5 Claire Graziani-Taugeron,5 Bleuenn Rault,5 Dahbia Horchi5 1MD, Janssen-Cilag, Cologno Monzese, MI, Italy; 2Medical Affairs, Ja
Externí odkaz:
https://doaj.org/article/54571611af0e4a04be57bd5291b630d4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Palumbo, A. *, Gay, F., Bringhen, S., Falcone, A., Pescosta, N., Callea, V., Caravita, T., Morabito, F., Magarotto, V., Ruggeri, M., Avonto, I., Musto, P., Cascavilla, N., Bruno, B., Boccadoro, M.
Publikováno v:
In Annals of Oncology June 2008 19(6):1160-1165
Autor:
Magarotto, V., Sonneveld, P., Voorhees, P., Paba-Prada, C., Plesner, T., Mellqvist, U. H., Byrne, C., Harmenberg, J., Nordstrom, E., Palumbo, A., Richardson, P.
Publikováno v:
Magarotto, V, Sonneveld, P, Voorhees, P, Paba-Prada, C, Plesner, T, Mellqvist, U H, Byrne, C, Harmenberg, J, Nordstrom, E, Palumbo, A & Richardson, P 2015, ' Encouraging Preliminary Data in Ongoing Open-Label Phase 1/2 Study of Safety and Efficacy of Melflufen and *Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma ', Haematologica, vol. 100, no. S1, P285, pp. 89 .
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3062::7ae8e80ead90333b24487f9be7eb9955
https://portal.findresearcher.sdu.dk/da/publications/7662dfc6-9289-4385-9555-34a1be402f67
https://portal.findresearcher.sdu.dk/da/publications/7662dfc6-9289-4385-9555-34a1be402f67
Autor:
Morabito, F, Bringhen, S, Larocca, A, Wijermans, P, Victoria Mateos, M, Gimsing, P, Mazzone, C, Gottardi, D, Omedè, P, Zweegman, S, José Lahuerta, J, Zambello, R, Musto, P, Magarotto, V, Schaafsma, M, Oriol, A, Juliusson, G, Cerrato, C, Catalano, L, Gentile, M, Isabel Turel, A, Liberati, Anna Marina, Cavalli, M, Rossi, D, Passera, R, Rosso, S, Beksac, M, Cavo, M, Waage, A, San Miguel, J, Boccadoro, M, Sonneveld, P, Palumbo, A, Offidani, M.
Publikováno v:
American Journal of Hematology, 89(4), 355-362. Wiley-Liss Inc.
Morabito, F, Bringhen, S, Larocca, A, Wijermans, P, Mateos, M V, Gimsing, P, Mazzone, C, Gottardi, D, Omede, P, Zweegman, S, Lahuerta, J J, Zambello, R, Musto, P, Magarotto, V, Schaafsma, M, Oriol, A, Juliusson, G, Cerrato, C, Catalano, L, Gentile, M, Turel, A I, Liberati, A M, Cavalli, M, Rossi, D, Passera, R, Rosso, S, Beksac, M, Cavo, M, Waage, A, San Miguel, J, Boccadoro, M, Sonneveld, P, Palumbo, A & Offidani, M 2014, ' Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study ', American Journal of Hematology, vol. 89, no. 4, pp. 355-362 . https://doi.org/10.1002/ajh.23641
Morabito, F, Bringhen, S, Larocca, A, Wijermans, P, Mateos, M V, Gimsing, P, Mazzone, C, Gottardi, D, Omede, P, Zweegman, S, Lahuerta, J J, Zambello, R, Musto, P, Magarotto, V, Schaafsma, M, Oriol, A, Juliusson, G, Cerrato, C, Catalano, L, Gentile, M, Turel, A I, Liberati, A M, Cavalli, M, Rossi, D, Passera, R, Rosso, S, Beksac, M, Cavo, M, Waage, A, San Miguel, J, Boccadoro, M, Sonneveld, P, Palumbo, A & Offidani, M 2014, ' Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study ', American Journal of Hematology, vol. 89, no. 4, pp. 355-362 . https://doi.org/10.1002/ajh.23641
Novel agents in combination with melphalan and prednisone (MP) significantly improved progression-free survival (PFS) and overall survival (OS) in multiple myeloma (MM). Randomized trials comparing MP plus bortezomib (VMP) versus MP plus thalidomide
Autor:
Gay, F, Bringhen, S, Offidani, M, Liberati, Am, Cellini, C, Magarotto, V, Benevolo, G, Aitoro, G, Patriarca, F, Omede, P, Conticello, C, Montefusco, V, Rossi, D, Palladino, C, Pour, L, Allegra, Alessandro, Pietrantuono, G, Falcone, Ap, Rocci, A, Zambello, R, Ledda, A, Gentili, S, Musto, P, Boccadoro, M, Hajek, R, Palumbo, A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3978::0e189b91e2ce27073a31b341179da8c2
http://hdl.handle.net/11570/2558314
http://hdl.handle.net/11570/2558314
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Palumbo, Antonio, Magarotto, V.
The treatment of multiple myeloma has undergone important changes in the last few years. The use of novel agents, such as the immunomodulatory drugs thalidomide and lenalidomide, and the proteasome inhibitor bortezomib, has increased the treatment op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::05b5631c65d4790e25d7dfcc9c80f884
https://europepmc.org/articles/PMC3301431/
https://europepmc.org/articles/PMC3301431/
Autor:
Cavo, M., Palumbo, A., Bringhen, S., DI RAIMONDO, Francesco, Patriarca, F., Rossi, D., Levi, A., Offidani, M., Montefusco, V., Narni, F., Zambello, R., Benevolo, G., Grasso, M., Falcone, A., Musto, P., Guglielmelli, T., Gherlinzoni, F., Gottardi, D., Musolino, C., DI RENZO, N., Masini, L., Cangialosi, C., Dore, F., Ballanti, S., Storti, S., Angelucci, E., Vallone, R., Magarotto, V., Morabito, F., Tosi, P., Boccadoro, M.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______4731::547bee9f66430a581da3ebb8a0a2eef1
http://hdl.handle.net/20.500.11769/74111
http://hdl.handle.net/20.500.11769/74111